Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Retained Earnings of $797.9 million for Q1 2026, up 45488.0% year-over-year from N/an in Q1 2025, and up 61149.81% quarter-over-quarter from -$1.3 million in Q4 2025.
Lantheus Holdings (LNTH) Retained Earnings (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Retained Earnings for 13 consecutive years, with $797.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 45488.0% year-over-year to $797.9 million; the TTM figure through Mar 2026 stood at $797.9 million (up 45488.0% YoY), while the FY2025 annual figure was -$1.3 million, up 19.07% from the prior year.
- Retained Earnings climbed to $797.9 million in Q1 2026 per LNTH's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $797.9 million in Q1 2026 and bottomed at -$178.3 million in Q1 2022.
- Historically, Retained Earnings has averaged $98.0 million across 5 years, with a median of -$1.2 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 159.59% — and 2025, when it surged 53737.74%.
- Lantheus Holdings' Retained Earnings stood at -$1.3 million in 2022, then jumped by 10703.89% to $133.5 million in 2023, then plunged by 101.21% to -$1.6 million in 2024, then increased by 19.07% to -$1.3 million in 2025, then jumped by 61149.81% to $797.9 million in 2026.
- Business Quant data shows LNTH's Retained Earnings at $797.9 million in Q1 2026, -$1.3 million in Q4 2025, and $625.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 872.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 872.95 Mn |
| Mar 31, 2026 | 797.92 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 625.42 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Sep 30, 2024 | -1.17 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | 264.57 Mn |
| Dec 31, 2023 | 133.50 Mn |
| Sep 30, 2023 | 30.12 Mn |
| Jun 30, 2023 | -952,000.00 |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | -178.26 Mn |
| Dec 31, 2021 | -485,000.00 |
| Sep 30, 2021 | -1.14 Mn |